Linganisha mbinu

	Kipimo cha Tathmini ya COPD	EORTC QLQ-C30
Nyanja	Matokeo ya Afya	Matokeo ya Afya
Familia	Process / pipeline	Process / pipeline
Mwaka wa asili	2009	1993
Mwanzilishi	Paul W. Jones et al.	Nico Aaronson et al.
Aina	Self-report symptom and impact questionnaire	Self-report quality of life questionnaire
Chanzo asilia	Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Kline Leidy, N. (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648-654.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Majina mbadala	CAT, COPD Assessment Test, COPD Assessment Tool	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Zinazohusiana	4	5
Muhtasari	The COPD Assessment Test (CAT) is a simple, rapid, patient-centered measure of COPD symptom burden and functional impact. Developed by Paul Jones and colleagues in 2009, this 8-item questionnaire captures how COPD affects cough, sputum, chest tightness, breathing difficulty, activity limitation, confidence, sleep, and energy. It is used worldwide in clinical practice to guide disease management decisions and as a primary outcome measure in COPD clinical trials.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.